Author

Lucas P. Nacusi

Observed names: Lucas Nacusi, Lucas P Nacusi, Nacusi, Lucas

Observed institutions: University of Minnesota, Mayo Clinic, University of Colorado Boulder, Genesegues (United States), Masonic Cancer Center, University of Tulsa

OpenAlex ID: A5084985213

The WAVE2 complex regulates T cell receptor signaling to integrins via Abl- and CrkL–C3G-mediated activation of Rap1

2008 · Jeffrey C. Nolz, Lucas P. Nacusi, et al. · The Journal of Cell Biology · 108

Ubiquitination of p21Cip1/WAF1 by SCFSkp2: Substrate Requirement and Ubiquitination Site Selection

2005 · Wei Wang, Lucas Nacusi, et al. · Biochemistry · 75

Targeting 5α-reductase for prostate cancer prevention and treatment

2011 · Lucas P. Nacusi, Donald J. Tindall · Nature Reviews Urology · 70

The Cistrome and Gene Signature of Androgen Receptor Splice Variants in Castration Resistant Prostate Cancer Cells

2014 · Ji Lu, Peter E. Lonergan, et al. · The Journal of Urology · 69

PI3K Links NKG2D Signaling to a CrkL Pathway Involved in Natural Killer Cell Adhesion, Polarity, and Granule Secretion

2009 · Colin M Segovis, Renee A Schoon, et al. · The Journal of Immunology · 58

Akt1 sequentially phosphorylates p27kip1 within a conserved but non-canonical region.

2006 · Lucas P Nacusi, Robert J Sheaff · Cell Division · 28

PDF

Androgen receptor abnormalities in castration-recurrent prostate cancer

2009 · Lucas P Nacusi, Donald J Tindall · Expert Review of Endocrinology & Metabolism · 27

Tenfibgen Ligand Nanoencapsulation Delivers Bi-Functional Anti-CK2 RNAi Oligomer to Key Sites for Prostate Cancer Targeting Using Human Xenograft Tumors in Mice

2014 · Janeen H. Trembley, Gretchen M. Unger, et al. · PLoS ONE · 20

PDF

CK2 targeted RNAi therapeutic delivered via malignant cell-directed tenfibgen nanocapsule: dose and molecular mechanisms of response in xenograft prostate tumors

2016 · Khalil Ahmed, Betsy T. Kren, et al. · Oncotarget · 17

Abstract 2924: Constitutively active androgen receptor splice variants function independently of full-length androgen receptor in a cell-based model of castrate-resistant prostate cancer

2012 · Peter E. Lonergan, Lucas P. Nacusi, et al. · Cancer Research · 16

Primers on Molecular Pathways: Nuclear Receptors in Pancreatic Cancer

2008 · Lucas P. Nacusi, Jose D. Debes · Pancreatology · 7

The WAVE2 complex regulates T cell receptor signaling to integrins via Abl- and CrkL–C3G-mediated activation of Rap1

2008 · Jeffrey C. Nolz, Lucas P. Nacusi, et al. · The Journal of Experimental Medicine · 5

Deregulation of Cell Cycle Machinery in Pancreatic Cancer

2007 · Lucas P. Nacusi, Robert J. Sheaff · Pancreatology · 4

Cell Cycle Control of Stem Cell Fate

2008 · Lucas Nacusi, Robert Sheaff · WORLD SCIENTIFIC eBooks · 1

Subcutaneous Delivery of Diagnostics and RNAi to Primary and Metatstatic Tumors via Actively-targeted sub-50 nm (s50) Capsules.

2023 · Viccie L Korman, Lucas Nacusi, et al.

PDF

Abstract 3746: A high dose priming strategy with the novel RNAi therapeutic GS-10 elevates RISC Ago2, Ago4 and GW182 protein levels to enhance RNAi efficacy in a metastatic solid tumor model.

2023 · Lucas P Nacusi, Vicci L Korman, et al.

PDF

Abstract 3746: A high dose priming strategy with the novel RNAi therapeutic GS-10 elevates RISC Ago2, Ago4 and GW182 protein levels to enhance RNAi efficacy in a metastatic solid tumor model

2016 · Lucas P. Nacusi, Vicci L. Korman, et al. · Cancer Research

Abstract 940: Inhibition of androgen receptor activity in refractory prostate cancer cells by the novel Millennium-Takeda compound T-1759243

2012 · Lucy J. Schmidt, Lucas P. Nacusi, et al. · Cancer Research

PI3-Kinase Links NKG2D Signaling to a CrkL Pathway Involved in Natural Killer Cell Adhesion, Polarity, and Granule Secretion (134.3)

2009 · Colin M Segovis, Renee A Schoon, et al. · The Journal of Immunology

Works count: 21

Citation count: 505

H-index: 10

I10-index: 10